Lymphoma Awareness Month

home / awareness-month / september-2022-lymphoma-awareness-month

Leukemia and Lymphoma Awareness Month, recognized in September every year, focuses on cancers that impact the blood and bone marrow. This page takes an in-depth look at innovations within the blood cancer space.

Kami J. Maddocks, MD, Provides Insight Into the Biggest Breakthroughs in Lymphoma Thus Far in 2022

Kami Maddocks, MD

September 1st 2022

Kami J. Maddocks, MD, talks CAR T-cell therapy approvals for the treatment of relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma plus a new treatment supplanting R-CHOP.

Kami J. Maddocks, MD, Details Important Updates in MCL Presented at Key Medical Meetings in 2022

Kami Maddocks, MD

September 12th 2022

Kami J. Maddocks, MD, reviews findings from the SHINE trial comparing ibrutinib plus bendamustine/rituximab vs bendamustine/rituximab alone in newly diagnosed mantle cell lymphoma.

Kami J. Maddocks, MD, Talks Updates in Hodgkin Lymphoma Using Brentuximab Vedotin and PD-1 Inhibitors

Kami Maddocks, MD

September 19th 2022

Kami J. Maddocks, MD, reviews updates to a pivotal trial supporting the use of brentuximab vedotin in advanced-stage Hodgkin lymphoma and ongoing research into PD-1 inhibitors in this space.

Kami J. Maddocks, MD, Reviews Ongoing Research Into Bispecific Antibodies and Other New Treatment Combinations for Lymphoma

Kami Maddocks, MD

September 22nd 2022

In an interview, Kami J. Maddocks, MD, showed her excitement about future use of bispecific antibodies for the treatment of lymphomas.

Kami J. Maddocks, MD, Shows Optimism for Future Development of Cellular Therapies in Lymphoma

Kami Maddocks, MD

September 26th 2022

In an interview, Kami J. Maddocks, MD, details therapies that may shake up the standard of care in lymphoma going forward.